Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.

× No keyword cloud information.

20 in total

1. Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo.

Authors: M Micallef; M Hosokawa; T Shibata; A Nakane; Z B Yang; T Minagawa; H Kobayashi
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

Review 2. Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

Authors: Carole Fournier; François Martin; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Lionel Apetoh
Journal: Oncoimmunology Date: 2017-08-11 Impact factor: 8.110

3. Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.

Authors: Robert S Nickel; Frank Keller; John Bergsagel; Todd Cooper; Marla Daves; Himalee Sabnis; Glen Lew
Journal: Pediatr Blood Cancer Date: 2013-12-19 Impact factor: 3.167

4. Curculigo orchioides Gaertn Effectively Ameliorates the Uro- and Nephrotoxicities Induced by Cyclophosphamide Administration in Experimental Animals.

Authors: Vishnu Priya Murali; Girija Kuttan
Journal: Integr Cancer Ther Date: 2015-09-29 Impact factor: 3.279

5. Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.

Authors: Hazem Ghebeh; Cynthia Lehe; Eman Barhoush; Khaldoon Al-Romaih; Asma Tulbah; Monther Al-Alwan; Siti-Faujiah Hendrayani; Pulicat Manogaran; Ayodele Alaiya; Taher Al-Tweigeri; Abdelilah Aboussekhra; Said Dermime
Journal: Breast Cancer Res Date: 2010-07-13 Impact factor: 6.466

Review 6. Immunogenic cell death and DAMPs in cancer therapy.

Authors: Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal: Nat Rev Cancer Date: 2012-11-15 Impact factor: 60.716

7. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.

Authors: Y Umeda; A Sakamoto; J Nakamura; H Ishitsuka; Y Yagi
Journal: Cancer Immunol Immunother Date: 1983 Impact factor: 6.968

8. Modulation of antitumoral antibody-dependent cellular cytotoxicity and natural killer activity by Adriamycin and daunorubicin.

Authors: R W Pfeifer; H B Bosmann
Journal: Agents Actions Date: 1982-12

9. Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.

Authors: L M Weiskirch; E Barker; M B Mokyr
Journal: Cancer Immunol Immunother Date: 1990 Impact factor: 6.968

Review 10. The anticancer immune response: indispensable for therapeutic success?

Authors: Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Fabrice André; Antoine Tesniere; Guido Kroemer
Journal: J Clin Invest Date: 2008-06 Impact factor: 14.808